Report for Fink-Jensen A

Title : Muscarinic Acetylcholine Receptor Subtypes as Potential Drug Targets for the Treatment of Schizophrenia, Drug Abuse and Parkinson's Disease - Dencker_2012_ACS.Chem.Neurosci_3_80

Author(s) : Dencker D , Thomsen M , Wortwein G , Weikop P , Cui Y , Jeon J , Wess J , Fink-Jensen A

Ref : ACS Chem Neurosci , 3 :80 , 2012

Abstract : Dencker_2012_ACS.Chem.Neurosci_3_80

ESTHER : Dencker_2012_ACS.Chem.Neurosci_3_80

PubMedSearch : Dencker_2012_ACS.Chem.Neurosci_3_80

PubMedID: 22389751

Title : An allosteric enhancer of M(4) muscarinic acetylcholine receptor function inhibits behavioral and neurochemical effects of cocaine - Dencker_2012_Psychopharmacology.(Berl)_224_277

Author(s) : Dencker D , Weikop P , Sorensen G , Woldbye DP , Wortwein G , Wess J , Fink-Jensen A

Ref : Psychopharmacology (Berl) , 224 :277 , 2012

Abstract : Dencker_2012_Psychopharmacology.(Berl)_224_277

ESTHER : Dencker_2012_Psychopharmacology.(Berl)_224_277

PubMedSearch : Dencker_2012_Psychopharmacology.(Berl)_224_277

PubMedID: 22648127

Title : Involvement of a subpopulation of neuronal M4 muscarinic acetylcholine receptors in the antipsychotic-like effects of the M1\/M4 preferring muscarinic receptor agonist xanomeline - Dencker_2011_J.Neurosci_31_5905

Author(s) : Dencker D , Wortwein G , Weikop P , Jeon J , Thomsen M , Sager TN , Mork A , Woldbye DP , Wess J , Fink-Jensen A

Ref : Journal of Neuroscience , 31 :5905 , 2011

Abstract : Dencker_2011_J.Neurosci_31_5905

ESTHER : Dencker_2011_J.Neurosci_31_5905

PubMedSearch : Dencker_2011_J.Neurosci_31_5905

PubMedID: 21508215

Title : Antipsychotic-induced catalepsy is attenuated in mice lacking the M4 muscarinic acetylcholine receptor - Fink-Jensen_2011_Eur.J.Pharmacol_656_39

Author(s) : Fink-Jensen A , Schmidt LS , Dencker D , Schulein C , Wess J , Wortwein G , Woldbye DP

Ref : European Journal of Pharmacology , 656 :39 , 2011

Abstract : Fink-Jensen_2011_Eur.J.Pharmacol_656_39

ESTHER : Fink-Jensen_2011_Eur.J.Pharmacol_656_39

PubMedSearch : Fink-Jensen_2011_Eur.J.Pharmacol_656_39

PubMedID: 21269601

Title : Increased cocaine self-administration in M4 muscarinic acetylcholine receptor knockout mice - Schmidt_2011_Psychopharmacology.(Berl)_216_367

Author(s) : Schmidt LS , Thomsen M , Weikop P , Dencker D , Wess J , Woldbye DP , Wortwein G , Fink-Jensen A

Ref : Psychopharmacology (Berl) , 216 :367 , 2011

Abstract : Schmidt_2011_Psychopharmacology.(Berl)_216_367

ESTHER : Schmidt_2011_Psychopharmacology.(Berl)_216_367

PubMedSearch : Schmidt_2011_Psychopharmacology.(Berl)_216_367

PubMedID: 21373792

Title : A subpopulation of neuronal M4 muscarinic acetylcholine receptors plays a critical role in modulating dopamine-dependent behaviors - Jeon_2010_J.Neurosci_30_2396

Author(s) : Jeon J , Dencker D , Wortwein G , Woldbye DP , Cui Y , Davis AA , Levey AI , Schutz G , Sager TN , Mork A , Li C , Deng CX , Fink-Jensen A , Wess J

Ref : Journal of Neuroscience , 30 :2396 , 2010

Abstract : Jeon_2010_J.Neurosci_30_2396

ESTHER : Jeon_2010_J.Neurosci_30_2396

PubMedSearch : Jeon_2010_J.Neurosci_30_2396

PubMedID: 20147565

Title : Attenuation of cocaine's reinforcing and discriminative stimulus effects via muscarinic M1 acetylcholine receptor stimulation - Thomsen_2010_J.Pharmacol.Exp.Ther_332_959

Author(s) : Thomsen M , Conn PJ , Lindsley C , Wess J , Boon JY , Fulton BS , Fink-Jensen A , Caine SB

Ref : Journal of Pharmacology & Experimental Therapeutics , 332 :959 , 2010

Abstract : Thomsen_2010_J.Pharmacol.Exp.Ther_332_959

ESTHER : Thomsen_2010_J.Pharmacol.Exp.Ther_332_959

PubMedSearch : Thomsen_2010_J.Pharmacol.Exp.Ther_332_959

PubMedID: 19996296

Title : Common variants conferring risk of schizophrenia - Stefansson_2009_Nature_460_744

Author(s) : Stefansson H , Ophoff RA , Steinberg S , Andreassen OA , Cichon S , Rujescu D , Werge T , Pietilainen OP , Mors O , Mortensen PB , Sigurdsson E , Gustafsson O , Nyegaard M , Tuulio-Henriksson A , Ingason A , Hansen T , Suvisaari J , Lonnqvist J , Paunio T , Borglum AD , Hartmann A , Fink-Jensen A , Nordentoft M , Hougaard D , Norgaard-Pedersen B , Bottcher Y , Olesen J , Breuer R , Moller HJ , Giegling I , Rasmussen HB , Timm S , Mattheisen M , Bitter I , Rethelyi JM , Magnusdottir BB , Sigmundsson T , Olason P , Masson G , Gulcher JR , Haraldsson M , Fossdal R , Thorgeirsson TE , Thorsteinsdottir U , Ruggeri M , Tosato S , Franke B , Strengman E , Kiemeney LA , Melle I , Djurovic S , Abramova L , Kaleda V , Sanjuan J , de Frutos R , Bramon E , Vassos E , Fraser G , Ettinger U , Picchioni M , Walker N , Toulopoulou T , Need AC , Ge D , Yoon JL , Shianna KV , Freimer NB , Cantor RM , Murray R , Kong A , Golimbet V , Carracedo A , Arango C , Costas J , Jonsson EG , Terenius L , Agartz I , Petursson H , Nothen MM , Rietschel M , Matthews PM , Muglia P , Peltonen L , St Clair D , Goldstein DB , Stefansson K , Collier DA

Ref : Nature , 460 :744 , 2009

Abstract : Stefansson_2009_Nature_460_744

ESTHER : Stefansson_2009_Nature_460_744

PubMedSearch : Stefansson_2009_Nature_460_744

PubMedID: 19571808

Title : Effects of donepezil adjunctive treatment to ziprasidone on cognitive deficits in schizophrenia: a double-blind, placebo-controlled study - Fagerlund_2007_Clin.Neuropharmacol_30_3

Author(s) : Fagerlund B , Soholm B , Fink-Jensen A , Lublin H , Glenthoj BY

Ref : Clinical Neuropharmacology , 30 :3 , 2007

Abstract : Fagerlund_2007_Clin.Neuropharmacol_30_3

ESTHER : Fagerlund_2007_Clin.Neuropharmacol_30_3

PubMedSearch : Fagerlund_2007_Clin.Neuropharmacol_30_3

PubMedID: 17272964

Title : The acetylcholinesterase inhibitor galantamine inhibits d-amphetamine-induced psychotic-like behavior in Cebus monkeys - Andersen_2007_J.Pharmacol.Exp.Ther_321_1179

Author(s) : Andersen MB , Werge T , Fink-Jensen A

Ref : Journal of Pharmacology & Experimental Therapeutics , 321 :1179 , 2007

Abstract : Andersen_2007_J.Pharmacol.Exp.Ther_321_1179

ESTHER : Andersen_2007_J.Pharmacol.Exp.Ther_321_1179

PubMedSearch : Andersen_2007_J.Pharmacol.Exp.Ther_321_1179

PubMedID: 17374745

Title : Decreased prepulse inhibition and increased sensitivity to muscarinic, but not dopaminergic drugs in M5 muscarinic acetylcholine receptor knockout mice - Thomsen_2007_Psychopharmacology.(Berl)_192_97

Author(s) : Thomsen M , Wortwein G , Fink-Jensen A , Woldbye DP , Wess J , Caine SB

Ref : Psychopharmacology (Berl) , 192 :97 , 2007

Abstract : Thomsen_2007_Psychopharmacology.(Berl)_192_97

ESTHER : Thomsen_2007_Psychopharmacology.(Berl)_192_97

PubMedSearch : Thomsen_2007_Psychopharmacology.(Berl)_192_97

PubMedID: 17310388

Title : Reduced cocaine self-administration in muscarinic M5 acetylcholine receptor-deficient mice - Thomsen_2005_J.Neurosci_25_8141

Author(s) : Thomsen M , Woldbye DP , Wortwein G , Fink-Jensen A , Wess J , Caine SB

Ref : Journal of Neuroscience , 25 :8141 , 2005

Abstract : Thomsen_2005_J.Neurosci_25_8141

ESTHER : Thomsen_2005_J.Neurosci_25_8141

PubMedSearch : Thomsen_2005_J.Neurosci_25_8141

PubMedID: 16148222

Title : Role for M5 muscarinic acetylcholine receptors in cocaine addiction - Fink-Jensen_2003_J.Neurosci.Res_74_91

Author(s) : Fink-Jensen A , Fedorova I , Wortwein G , Woldbye DP , Rasmussen T , Thomsen M , Bolwig TG , Knitowski KM , McKinzie DL , Yamada M , Wess J , Basile A

Ref : Journal of Neuroscience Research , 74 :91 , 2003

Abstract : Fink-Jensen_2003_J.Neurosci.Res_74_91

ESTHER : Fink-Jensen_2003_J.Neurosci.Res_74_91

PubMedSearch : Fink-Jensen_2003_J.Neurosci.Res_74_91

PubMedID: 13130510

Title : The muscarinic receptor agonist BuTAC, a novel potential antipsychotic, does not impair learning and memory in mouse passive avoidance - Rasmussen_2001_Schizophr.Res_49_193

Author(s) : Rasmussen T , Fink-Jensen A , Sauerberg P , Swedberg MD , Thomsen C , Sheardown MJ , Jeppesen L , Calligaro DO , DeLapp NW , Whitesitt CA , Ward JS , Shannon HE , Bymaster FP

Ref : Schizophr Res , 49 :193 , 2001

Abstract : Rasmussen_2001_Schizophr.Res_49_193

ESTHER : Rasmussen_2001_Schizophr.Res_49_193

PubMedSearch : Rasmussen_2001_Schizophr.Res_49_193

PubMedID: 11343877

Title : Xanomeline, an M(1)\/M(4) preferring muscarinic cholinergic receptor agonist, produces antipsychotic-like activity in rats and mice - Shannon_2000_Schizophr.Res_42_249

Author(s) : Shannon HE , Rasmussen K , Bymaster FP , Hart JC , Peters SC , Swedberg MD , Jeppesen L , Sheardown MJ , Sauerberg P , Fink-Jensen A

Ref : Schizophr Res , 42 :249 , 2000

Abstract : Shannon_2000_Schizophr.Res_42_249

ESTHER : Shannon_2000_Schizophr.Res_42_249

PubMedSearch : Shannon_2000_Schizophr.Res_42_249

PubMedID: 10785583

Title : Muscarinic receptor agonists decrease cocaine self-administration rates in drug-naive mice - Rasmussen_2000_Eur.J.Pharmacol_402_241

Author(s) : Rasmussen T , Sauerberg P , Nielsen EB , Swedberg MD , Thomsen C , Sheardown MJ , Jeppesen L , Calligaro DO , DeLapp NW , Whitesitt CA , Ward JS , Shannon HE , Bymaster FP , Fink-Jensen A

Ref : European Journal of Pharmacology , 402 :241 , 2000

Abstract : Rasmussen_2000_Eur.J.Pharmacol_402_241

ESTHER : Rasmussen_2000_Eur.J.Pharmacol_402_241

PubMedSearch : Rasmussen_2000_Eur.J.Pharmacol_402_241

PubMedID: 10958890

Title : Poster: Muscarinic receptor characterization and neurochemical effects of the antipsychotic-like muscarinic agonist PTAC -

Author(s) : Bymaster FP , Shannon HE , DeLapp NW , Calligaro DO , Perry KW , Zhang W , Rasmussen K , Ward JS , Fink-Jensen A , Olesen PH , Rasmussen T , Sheardown M , Swedberg MD , Jeppesen L , Sauerberg P

Ref : Life Sciences , 64 :579 , 1999

PubMedID:

Title : Poster: Behavioral and electrophysiological effects of the antipsychotic-like muscarinic agonist PTAC -

Author(s) : Shannon HE , Bymaster FP , Rasmussen K , DeLapp NW , Calligaro DO , Perry KW , Mitch CH , Ward JS , Fink-Jensen A , Olesen PH , Rasmussen T , Sheardown M , Swedberg MD , Jeppesen L , Sauerberg P

Ref : Life Sciences , 64 :587 , 1999

PubMedID:

Title : Potential role of muscarinic receptors in schizophrenia - Bymaster_1999_Life.Sci_64(6-7)_527

Author(s) : Bymaster FP , Shannon HE , Rasmussen K , DeLapp NW , Ward JS , Calligaro DO , Mitch CH , Whitesitt CA , Ludvigsen TS , Sheardown MJ , Swedberg MD , Rasmussen T , Olesen PH , Jeppesen L , Sauerberg P , Fink-Jensen A

Ref : Life Sciences , 64 :527 , 1999

Abstract : Bymaster_1999_Life.Sci_64(6-7)_527

ESTHER : Bymaster_1999_Life.Sci_64(6-7)_527

PubMedSearch : Bymaster_1999_Life.Sci_64(6-7)_527

PubMedID: 10069519

Title : Poster: Determination of the intrinsic functional muscarinic activity of xanomeline -

Author(s) : Falcone JF , Bymaster FP , Butler T , Thomsen C , Calligaro DO , Shannon HE , Whitesitt C , Ward J , Sheardown M , Fink-Jensen A , Jeppesen L , Sauerberg P , DeLapp NC

Ref : Life Sciences , 64 :579 , 1999

PubMedID:

Title : Muscarinic receptor agonists, like dopamine receptor antagonist antipsychotics, inhibit conditioned avoidance response in rats - Shannon_1999_J.Pharmacol.Exp.Ther_290_901

Author(s) : Shannon HE , Hart JC , Bymaster FP , Calligaro DO , DeLapp NW , Mitch CH , Ward JS , Fink-Jensen A , Sauerberg P , Jeppesen L , Sheardown MJ , Swedberg MD

Ref : Journal of Pharmacology & Experimental Therapeutics , 290 :901 , 1999

Abstract : Shannon_1999_J.Pharmacol.Exp.Ther_290_901

ESTHER : Shannon_1999_J.Pharmacol.Exp.Ther_290_901

PubMedSearch : Shannon_1999_J.Pharmacol.Exp.Ther_290_901

PubMedID: 10411607

Title : Poster: Muscarinic agonists with antipsychotic-like activity. Structure activity-relationships of 1,2,5-thiadiazole analogues with functioally dopamine antagonist activity -

Author(s) : Sauerberg P , Jeppesen L , Olesen PH , Rasmussen T , Swedberg MD , Sheardown MJ , Fink-Jensen A , Thomsen C , Thogersen H , Ward JS , Calligaro DO , DeLapp NW , Bymaster FP , Shannon HE

Ref : Life Sciences , 64 :555 , 1999

PubMedID:

Title : Poster: New potent muscarinic 1,2,5-thiadiazole-azacycles and dimers hereof -

Author(s) : Jeppesen L , Sauerberg P , Olesen PH , Sheardown MJ , Thomsen C , Rasmussen T , Fink-Jensen A , Christensen MS , Ward JS , Whitesitt C , Calligaro DO , Bymaster FP , DeLapp NW , Felder CC , Shannon HE

Ref : Life Sciences , 64 :555 , 1999

PubMedID:

Title : Muscarinic agonists exhibit functional dopamine antagonism in unilaterally 6-OHDA lesioned rats - Fink-Jensen_1998_Neuroreport_9_3481

Author(s) : Fink-Jensen A , Kristensen P , Shannon HE , Calligaro DO , DeLapp NW , Whitesitt CA , Ward JS , Thomsen C , Rasmusseen T , Sheardown MJ , Jeppesen L , Sauerberg P , Bymaster FP

Ref : Neuroreport , 9 :3481 , 1998

Abstract : Fink-Jensen_1998_Neuroreport_9_3481

ESTHER : Fink-Jensen_1998_Neuroreport_9_3481

PubMedSearch : Fink-Jensen_1998_Neuroreport_9_3481

PubMedID: 9855303

Title : Muscarinic agonists with antipsychotic-like activity: structure-activity relationships of 1,2,5-thiadiazole analogues with functional dopamine antagonist activity - Sauerberg_1998_J.Med.Chem_41_4378

Author(s) : Sauerberg P , Jeppesen L , Olesen PH , Rasmussen T , Swedberg MD , Sheardown MJ , Fink-Jensen A , Thomsen C , Thogersen H , Rimvall K , Ward JS , Calligaro DO , DeLapp NW , Bymaster FP , Shannon HE

Ref : Journal of Medicinal Chemistry , 41 :4378 , 1998

Abstract : Sauerberg_1998_J.Med.Chem_41_4378

ESTHER : Sauerberg_1998_J.Med.Chem_41_4378

PubMedSearch : Sauerberg_1998_J.Med.Chem_41_4378

PubMedID: 9784113

Title : Identification of side chains on 1,2,5-thiadiazole-azacycles optimal for muscarinic m1 receptor activation - Sauerberg_1998_Bioorg.Med.Chem.Lett_8_2897

Author(s) : Sauerberg P , Jeppesen L , Olesen PH , Sheardown MJ , Fink-Jensen A , Rasmussen T , Rimvall K , Shannon HE , Bymaster FP , DeLapp NW , Calligaro DO , Ward JS , Whitesitt CA , Thomsen C

Ref : Bioorganic & Medicinal Chemistry Lett , 8 :2897 , 1998

Abstract : Sauerberg_1998_Bioorg.Med.Chem.Lett_8_2897

ESTHER : Sauerberg_1998_Bioorg.Med.Chem.Lett_8_2897

PubMedSearch : Sauerberg_1998_Bioorg.Med.Chem.Lett_8_2897

PubMedID: 9873644

Title : Xanomeline compared to other muscarinic agents on stimulation of phosphoinositide hydrolysis in vivo and other cholinomimetic effects - Bymaster_1998_Brain.Res_795_179

Author(s) : Bymaster FP , Carter PA , Peters SC , Zhang W , Ward JS , Mitch CH , Calligaro DO , Whitesitt CA , DeLapp NC , Shannon HE , Rimvall K , Jeppesen L , Sheardown MJ , Fink-Jensen A , Sauerberg P

Ref : Brain Research , 795 :179 , 1998

Abstract : Bymaster_1998_Brain.Res_795_179

ESTHER : Bymaster_1998_Brain.Res_795_179

PubMedSearch : Bymaster_1998_Brain.Res_795_179

PubMedID: 9622623

Title : Unexpected antipsychotic-like activity with the muscarinic receptor ligand (5R,6R)6-(3-propylthio-1,2,5-thiadiazol-4-yl)-1-azabicyclo[3.2.1]octane - Bymaster_1998_Eur.J.Pharmacol_356_109

Author(s) : Bymaster FP , Shannon HE , Rasmussen K , DeLapp NW , Mitch CH , Ward JS , Calligaro DO , Ludvigsen TS , Sheardown MJ , Olesen PH , Swedberg MD , Sauerberg P , Fink-Jensen A

Ref : European Journal of Pharmacology , 356 :109 , 1998

Abstract : Bymaster_1998_Eur.J.Pharmacol_356_109

ESTHER : Bymaster_1998_Eur.J.Pharmacol_356_109

PubMedSearch : Bymaster_1998_Eur.J.Pharmacol_356_109

PubMedID: 9774240

Title : Poster: Stimulation of phosphoinositide hydrolysis in vivo by xanomeline and other muscarinic agents -

Author(s) : Bymaster FP , Carter PA , Shannon HE , DeLapp NC , Whitesitt CA , Ward JS , Calligaro DO , Mitch CH , Sheardown MJ , Swedberg MD , Rimvall K , Fink-Jensen A , Jeppesen L , Sauerberg P

Ref : Life Sciences , 60 :1165 , 1997

PubMedID:

Title : In vivo pharmacology of butylthio[2.2.2] (LY297802 \/ NNC11-1053), an orally acting antinociceptive muscarinic agonist - Shannon_1997_Life.Sci_60(13-14)_969

Author(s) : Shannon HE , Womer DE , Bymaster FP , Calligaro DO , DeLapp NC , Mitch CH , Ward JS , Whitesitt CA , Swedberg MD , Sheardown MJ , Fink-Jensen A , Olesen PH , Rimvall K , Sauerberg P

Ref : Life Sciences , 60 :969 , 1997

Abstract : Shannon_1997_Life.Sci_60(13-14)_969

ESTHER : Shannon_1997_Life.Sci_60(13-14)_969

PubMedSearch : Shannon_1997_Life.Sci_60(13-14)_969

PubMedID: 9121363

Report for Fink-Jensen A

General

References (30)

Report for Fink-Jensen A

General

References (30)

1. Muscarinic Acetylcholine Receptor Subtypes as Potential Drug Targets for the Treatment of Schizophrenia, Drug Abuse and Parkinson's Disease

2. An allosteric enhancer of M(4) muscarinic acetylcholine receptor function inhibits behavioral and neurochemical effects of cocaine

3. Involvement of a subpopulation of neuronal M4 muscarinic acetylcholine receptors in the antipsychotic-like effects of the M1\/M4 preferring muscarinic receptor agonist xanomeline

4. Antipsychotic-induced catalepsy is attenuated in mice lacking the M4 muscarinic acetylcholine receptor

5. Increased cocaine self-administration in M4 muscarinic acetylcholine receptor knockout mice

6. A subpopulation of neuronal M4 muscarinic acetylcholine receptors plays a critical role in modulating dopamine-dependent behaviors

7. Attenuation of cocaine's reinforcing and discriminative stimulus effects via muscarinic M1 acetylcholine receptor stimulation

8. Common variants conferring risk of schizophrenia

9. Effects of donepezil adjunctive treatment to ziprasidone on cognitive deficits in schizophrenia: a double-blind, placebo-controlled study

10. The acetylcholinesterase inhibitor galantamine inhibits d-amphetamine-induced psychotic-like behavior in Cebus monkeys

11. Decreased prepulse inhibition and increased sensitivity to muscarinic, but not dopaminergic drugs in M5 muscarinic acetylcholine receptor knockout mice

12. Reduced cocaine self-administration in muscarinic M5 acetylcholine receptor-deficient mice

13. Role for M5 muscarinic acetylcholine receptors in cocaine addiction

14. The muscarinic receptor agonist BuTAC, a novel potential antipsychotic, does not impair learning and memory in mouse passive avoidance

15. Xanomeline, an M(1)\/M(4) preferring muscarinic cholinergic receptor agonist, produces antipsychotic-like activity in rats and mice

16. Muscarinic receptor agonists decrease cocaine self-administration rates in drug-naive mice

17. Poster: Muscarinic receptor characterization and neurochemical effects of the antipsychotic-like muscarinic agonist PTAC

18. Poster: Behavioral and electrophysiological effects of the antipsychotic-like muscarinic agonist PTAC

19. Potential role of muscarinic receptors in schizophrenia

20. Poster: Determination of the intrinsic functional muscarinic activity of xanomeline

21. Muscarinic receptor agonists, like dopamine receptor antagonist antipsychotics, inhibit conditioned avoidance response in rats

22. Poster: Muscarinic agonists with antipsychotic-like activity. Structure activity-relationships of 1,2,5-thiadiazole analogues with functioally dopamine antagonist activity

23. Poster: New potent muscarinic 1,2,5-thiadiazole-azacycles and dimers hereof

24. Muscarinic agonists exhibit functional dopamine antagonism in unilaterally 6-OHDA lesioned rats

25. Muscarinic agonists with antipsychotic-like activity: structure-activity relationships of 1,2,5-thiadiazole analogues with functional dopamine antagonist activity

26. Identification of side chains on 1,2,5-thiadiazole-azacycles optimal for muscarinic m1 receptor activation

27. Xanomeline compared to other muscarinic agents on stimulation of phosphoinositide hydrolysis in vivo and other cholinomimetic effects

28. Unexpected antipsychotic-like activity with the muscarinic receptor ligand (5R,6R)6-(3-propylthio-1,2,5-thiadiazol-4-yl)-1-azabicyclo[3.2.1]octane

29. Poster: Stimulation of phosphoinositide hydrolysis in vivo by xanomeline and other muscarinic agents

30. In vivo pharmacology of butylthio[2.2.2] (LY297802 \/ NNC11-1053), an orally acting antinociceptive muscarinic agonist